News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xcyte Therapies, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock



10/19/2005 5:13:16 PM

Xcyte Therapies, Inc. ("Xcyte", the "Company") (Nasdaq:XCYT) announced today that the Company's Board of Directors has declared a quarterly dividend in the amount of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock (the "Preferred Stock") in accordance with the terms thereof. Xcyte issued 2,990,000 shares of the Preferred Stock in November 2004. As of April 8, 2005, approximately 943,000 shares of the Preferred Stock have been converted to the Company's common stock. The dividend on the Preferred Stock will be paid on May 2, 2005, to the holders of record as of the close of business on April 22, 2005.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES